The PROACT LUNG Study: A Prospective Observational Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening

Sponsor:

Freenome, Inc

Sponsor Study ID:

FRNM-007

CTO #:

103995

NCT Number:

NCT06122077

Phase:

N/A

Protocol Type:

Diagnostic

Age Group:

Adults

Disease Sites:

Lung

Study Objectives:

Primary Objective To evaluate the clinical performance of the FMBT-Lung (clinical validation), including sensitivity and specificity, in detecting lung cancer among subjects with positive and negative lung cancer outcomes during a 12-month follow-up period. 2.4 Secondary Objective To evaluate the clinical performance of the FMBT-Lung, including sensitivity and specificity, in detecting lung cancer among subjects with positive and negative lung cancer outcomes, during a 24-month follow-up period.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)